Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongshuo Liu

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 28, 2023
STUB1/CHIP: New insights in cancer and immunityYongshuo Liu, Honghong Zhou, Xiaolong Tang
Heliyon|January 23, 2023
Immune checkpoint PTPN2 predicts prognosis and immunotherapy response in human cancersXiaolong Tang, Xue Sui, Yongshuo Liu
Disease Markers|January 30, 2023
High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell CycleXiaolong Tang, Honghong Zhou, Yongshuo Liu
Frontiers in Immunology|December 17, 2021
SNAIL1: Linking Tumor Metastasis to Immune EvasionXiaolong Tang, Xue Sui, Liang Weng, et al.
International Journal of Biological Macromolecules|May 7, 2026
Corrigendum to "TIMP1 and PKM drive immunosuppression and metabolic remodeling to promote colorectal cancer progression through integrated multi-omics analysis" [International Journal of Biological Macromolecules; Volume: 360 Issue: May 2026; Article number: 151944; DOI: https://doi.org/10.1016/j.ijbiomac.2026.151944]Yukai Wang, Wei Zhang, Yongshuo Liu, et al.
Biochemical and Biophysical Research Communications|January 22, 2022
Identification of ERCC8 as a novel cisplatin-resistant gene in esophageal cancer based on genome-scale CRISPR/Cas9 screeningXue Sui, Xiaolong Tang, Xi Wu, et al.
Heliyon|August 26, 2022
A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinomaXiaolong Tang, Chumei Qi, Honghong Zhou, et al.
International Journal of Biological Macromolecules|April 12, 2026
TIMP1 and PKM drive immunosuppression and metabolic remodeling to promote colorectal cancer progression through integrated multi-omics analysisYukai Wang, Wei Zhang, Yongshuo Liu, et al.
Frontiers in Oncology|August 12, 2022
Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapyXiaolong Tang, Chumei Qi, Honghong Zhou, et al.
Scientific Reports|November 7, 2022
Research On Maize Disease Identification Methods In Complex Environments Based On Cascade Networks And Two-Stage Transfer LearningHongxin Liu, Haichen Lv, Jiajun Li, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 28, 2023
STUB1/CHIP: New insights in cancer and immunityYongshuo Liu, Honghong Zhou, Xiaolong Tang
Heliyon|January 23, 2023
Immune checkpoint PTPN2 predicts prognosis and immunotherapy response in human cancersXiaolong Tang, Xue Sui, Yongshuo Liu
Disease Markers|January 30, 2023
High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell CycleXiaolong Tang, Honghong Zhou, Yongshuo Liu
Frontiers in Immunology|December 17, 2021
SNAIL1: Linking Tumor Metastasis to Immune EvasionXiaolong Tang, Xue Sui, Liang Weng, et al.
International Journal of Biological Macromolecules|May 7, 2026
Corrigendum to "TIMP1 and PKM drive immunosuppression and metabolic remodeling to promote colorectal cancer progression through integrated multi-omics analysis" [International Journal of Biological Macromolecules; Volume: 360 Issue: May 2026; Article number: 151944; DOI: https://doi.org/10.1016/j.ijbiomac.2026.151944]Yukai Wang, Wei Zhang, Yongshuo Liu, et al.
Biochemical and Biophysical Research Communications|January 22, 2022
Identification of ERCC8 as a novel cisplatin-resistant gene in esophageal cancer based on genome-scale CRISPR/Cas9 screeningXue Sui, Xiaolong Tang, Xi Wu, et al.
Heliyon|August 26, 2022
A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinomaXiaolong Tang, Chumei Qi, Honghong Zhou, et al.
International Journal of Biological Macromolecules|April 12, 2026
TIMP1 and PKM drive immunosuppression and metabolic remodeling to promote colorectal cancer progression through integrated multi-omics analysisYukai Wang, Wei Zhang, Yongshuo Liu, et al.
Frontiers in Oncology|August 12, 2022
Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapyXiaolong Tang, Chumei Qi, Honghong Zhou, et al.
Scientific Reports|November 7, 2022
Research On Maize Disease Identification Methods In Complex Environments Based On Cascade Networks And Two-Stage Transfer LearningHongxin Liu, Haichen Lv, Jiajun Li, et al.
Pageof 3